Latest news from ATCC
ATCC Announces Award from the NCI to Provide Biospecimen Processing Services and Assays for Cancer Research
NCI awarded ATCC a five-year contract with a ceiling value of $7.37 million to provide biospecimen processing services and assays for cancer research.
ATCC and Tissue Dynamics Announce Strategic Collaboration to Bring a Transformative Heart Organoid Model to Market
ATCC and Tissue Dynamics announced a partnership to develop workflow-friendly cardiac organoid-based kits for improved cardiac safety testing in drug development.
ATCC Announces New Award from BARDA to Provide Centralized Storage and Bioprocessing Services for Project NextGen
ATCC announced a 5-year, $87 million award from BARDA to support the development of next-generation medical countermeasures.
ATCC Announces Award from NIAID to Consolidate its BEI Resources and NIH HIV Reagent Programs
ATCC announced a seven-year contract, with an initial award of over $21.5 million, from NIAID to continue the management of the newly merged NIH HIV Reagent Program with the BEI Resources Program.